Key Takeaways
- Cerebras (CBRS) stock declined over 3% Tuesday following Freedom Capital’s initiation of coverage with a Hold rating.
- First-quarter revenue surged 92% annually to $193.4 million, though gross margin projections disappointed market participants.
- Management forecasts 2026 core revenue between $855 million and $865 million, representing approximately 69% annual growth.
- The AI chipmaker secured a $20 billion multi-year agreement with OpenAI and launched a strategic partnership with Amazon Web Services.
- Analyst consensus shows an average price target of $299.30, suggesting 44% potential upside from current trading levels.
Shares of Cerebras Systems experienced a decline exceeding 3% during Tuesday’s session, trading significantly beneath their 52-week peak. The downturn followed Freedom Capital analyst Paul Meeks initiating coverage of the artificial intelligence semiconductor company with a Hold recommendation and establishing a $209 price objective.
The equity has experienced volatility throughout recent months. Following its Nasdaq introduction on May 14 at $185 per share, the stock initially rallied before entering a persistent decline. Last week, shares temporarily fell beneath the initial public offering price.
Meeks indicated that Cerebras hadn’t captured his attention prior to the post-earnings retreat. However, the subsequent price correction altered his perspective, despite identifying potential risks that market participants may have overlooked.
Quarterly Financial Performance Analysis
Cerebras unveiled its inaugural public company earnings report following market close on June 23. Revenue expanded 92% year-over-year, reaching $193.4 million. The net loss contracted to $14 million compared with $23.9 million in the corresponding prior-year period.
Hardware-related revenue increased 60% to $111.6 million. Cloud services and additional revenue streams jumped 167% to $79.8 million. These figures exceeded analyst projections.
Investor concerns emerged from gross margin forward guidance. While margins had improved from 42.1% one year prior to 46.5% in the first quarter, Cerebras projected margins would compress to a range of 38% to 41% for the complete fiscal year.
Executive leadership clarified that the company elected to temporarily lease back systems from a current customer during the construction phase of its proprietary data center infrastructure. The chief executive later noted that investors misinterpreted the guidance, emphasizing that the margin compression stemmed from this isolated strategic decision rather than fundamental business challenges.
Strategic Position and Market Outlook
Cerebras manufactures oversized, wafer-scale inference processors requiring specialized thermal management solutions. Due to their substantial dimensions, the company exclusively markets them as integrated systems rather than individual components.
The organization has secured significant strategic relationships. A $20 billion multi-year contract with OpenAI was finalized in December. Additionally, the company established an agreement with Amazon Web Services to integrate Amazon’s Trainium chip with Cerebras’ CS-3 system within AWS infrastructure.
The AWS collaboration isn’t anticipated to generate substantial revenue until 2027. Currently, Cerebras relies on its established hardware sales and cloud operations to achieve financial objectives.
For the second quarter, Cerebras anticipates revenue will increase 88% to $194 million. Full-year core revenue guidance ranges from $855 million to $865 million, translating to approximately 69% expansion.
Meeks identified two primary revenue streams for Cerebras’ future trajectory. The first involves marketing CS-3 systems for rapid AI inference applications. The second focuses on collaborating with hyperscale providers to distribute inference workloads, utilizing competing GPUs for initial processing stages and Cerebras’ processors for the decoding phase.
He perceives greater long-term potential in the latter business segment. Meeks also observed that the recent valuation decline has mitigated much of the investment risk present during earlier periods.
Nevertheless, Meeks cautioned that the recent floor of $161 may not necessarily serve as reliable support. He maintains that if Cerebras achieves its goal of tripling revenue in 2027, the stock presents considerably more appreciation potential than downside risk.
Prior to Meeks’ Hold recommendation, Wall Street maintained a unanimous Strong Buy consensus across 10 covering analysts. The average price objective of $299.30 indicates 44% upside potential from present trading levels.
CBRS shares were trading near $214 during Tuesday’s session, down from a 52-week peak of $386.34 and above the 52-week floor of $160.81.
